GeoVax Labs, Inc.

GOVX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Assets
Cash & Equivalents $3.1M $5.5M $6.5M $27.6M $11.4M $9.9M $283.3K $259.7K
Accounts Receivable $0 $659.4K $0 — — — — —
Inventory — — — — — — — —
Total Current Assets $5.3M $7.9M $7.9M $28.9M $11.6M $10.2M $447.3K $619.7K
Property, Plant & Equipment $108.8K $150.0K $209.7K $234.9K $156.9K $147.7K $10.6K $11.4K
Goodwill — — — — — — — —
Intangible Assets (Excl. Goodwill) — — — — — — — —
Total Assets $6.3M $8.2M $9.3M $31.3M $11.8M $10.4M $468.9K $642.1K
Liabilities
Accounts Payable $790.8K $1.8M $2.8M $1.7M $2.1M $267.7K $152.7K $125.9K
Total Current Liabilities $1.9M $3.1M $3.5M $4.7M $5.4M $810.3K $2.0M $1.6M
Long-Term Debt — — — — — — — —
Total Liabilities $2.5M $3.1M $3.5M $4.7M $7.4M $825.0K $2.0M $1.7M
Stockholders' Equity
Retained Earnings $-150.8M $-129.4M $-104.4M $-78.4M $-64.4M $-45.8M $-42.8M $-40.5M
Total Stockholders' Equity $3.8M $5.0M $5.8M $26.6M $4.4M $9.6M $-1.6M $-1.0M
← Newer Page 1 of 2 Older →